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Polyubiquitin has long been recognised as an
intracellular signal. It now appears that different lysine
linkages between the ubiquitin moieties are recognised
as distinct signals and act in different cell processes.
The generation of these different polyubiquitin chains
may play an important part in the life of a cell.
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The ubiquitin pathway is found in all eukaryotes. In this
pathway, target proteins are covalently modified by the
attachment of ubiquitin, a 76 residue protein, to specific
lysine residues [1]. Although the ability of ubiquitin to
function as a signal to target proteins for degradation by
the 26S proteasome is well documented, recent work from
a number of different laboratories has begun to indicate
that ubiquitin modification may play a more general role
as an intracellular signal. It now appears that that distinct
polyubiquitin signals that act in different cell processes
can be created by variation in the type of lysine linkage
between the ubiquitin moieties.
Ubiquitin molecules are added to target proteins by an
enzyme cascade [1]. First, the ubiquitin activating enzyme,
or E1 enzyme, activates the ubiquitin molecule by forming
a thioester bond between a conserved cysteine residue in
the enzyme’s active site and the glycine at position 76 in
the carboxy-terminal end of the ubiquitin molecule. This
reaction requires ATP. The ubiquitin is then passed on to
the ubiquitin conjugating enzyme, or E2 enzyme, again
with the formation of a thioester bond between the ubiqui-
tin molecule and the E2 enzyme. The E2 enzyme transfers
the activated ubiquitin to a lysine residue of the substrate
protein, either directly or in cooperation with specific ubiq-
uitin ligases or E3 enzymes. Most species have only one
E1 enzyme and multiple E2 and E3 enzymes. 
The selection of substrates for ubiquitination seems mostly
determined by direct interactions between the E3 enzymes
and the target proteins. A lysine residue on the ubiquitin
conjugated to the substrate can then act as an donor for the
activated ubiquitin, and this process can be repeated many
times to give a long polyubiquitin chain attached to the
substrate. These polyubiquitin chains then function as
intracellular signals. The best known example of this, of
course, is their role as degradation signals detected by the
proteasome. Polyubiquitin detection is thought to be medi-
ated by the 19S regulatory part of the 26S proteasome. This
part of the proteasome is itself a large and complex multi-
subunit assemblage; so far, however, only one polyubiqui-
tin receptor protein, the Rpn10 or S5a proteasome subunit,
has been identified [2]. In in vitro binding studies, the
Rpn10 protein recognised only chains that were greater
than four ubiquitin moieties long and the efficiency of
binding was found to increase with chain length.
Ubiquitin has seven lysine amino acid residues which can
potentially act donors to form ubiquitin chains. It appears
that the same lysine residue is used as a donor on each
ubiquitin moiety of the growing chain to form the isopep-
tide bond between the lysine residue on the conjugated
ubiquitin and the carboxy-terminal glycine residue of the
next activated ubiquitin molecule. The polyubiquitin
chain is therefore composed of ubiquitin monomers which
are all linked to each other using the same donor lysine
residue. All seven lysine residues of the ubiquitin mole-
cule have been shown to be capable of linking together to
form chains in vitro, and chains linked between four of
these lysines — K11, K29, K48 and K63 —have been
detected in vivo [3]. This variation clearly offers the
opportunity of creating a variety of different types of
signal with different downstream consequences.
The function of each of these different types of chain has
been investigated in a series of genetic experiments
carried out in budding yeast. The seven different lysine
residues in the ubiquitin molecule were mutated individ-
ually by site-directed mutagenesis and the outcome deter-
mined in cells deleted for the genomic ubiquitin genes
[4,5]. The conclusion from these experiments was that
only mutations to lysine 48 appeared to show a dramatic
defect in proteolysis; cells expressing the ubiquitin K48R
mutation arrested in mitosis with a phenotype reminiscent
of that caused by proteasome mutations. 
These genetic results strongly suggested that K48-linked
chains act as a signal for substrates to be recognised and
degraded by the 26S proteasome. In contrast, mutations of
ubiquitin residue K63 caused no obvious proteolytic
defects. These mutant cells were, however, sensitive to
DNA-damaging agents, such as methyl methane-
sulphonate (MMS) and ultra-violet light, indicating that
K63-linked polyubiquitin chains are involved, somehow,
in mediating the post-replicative DNA repair response.
Furthermore, overexpression of the K63R mutant ubiqui-
tin conferred stress sensitivity, suggesting a possible
involvement in the stress response [6]. Mutations of the
other lysine residues caused no obvious phenotypes, so
the functions of polyubiquitin chains linked by these
residues, if any, remain elusive.
Two recent studies [7,8] have extended our knowledge of
the formation of polyubiquitin chains and their role in
intracellular regulation. Both studies have identified new
factors which act, in addition to the well-characterised E1,
E2 and E3 enzymes, to add polyubiquitin chains to sub-
strate proteins. The discovery by Hofman and Pickart [7]
stemmed from the identification of a mammalian E2
specifically involved in the formation of K63-linked
polyubiquitin chains. The gene encoding this E2 protein
turned out to be the orthologue of the budding yeast gene
UBC13. Surprisingly, the authors found that, unlike previ-
ously characterised E2s, the Ubc13 protein could not form
chains by itself, but needed the presence of a cofactor.
This cofactor was purified from erythrocyte lysate by
affinity chromatography, and two proteins with the
desired activity were identified by mass spectrometry.
Both proteins turned out to be known members of the
‘ubiquitin-conjugation enzyme variant’ (UEV) family,
Mms2 and UEV1. 
Members of the UEV family of proteins bear a striking
similarity to the E2 ubiquitin conjugating proteins, but
lack the active site. Previously, it had been postulated
that the UEV proteins acted in a dominant-negative
manner to regulate E2 activity, but Hofman and Pickart
[7] demonstrated convincingly that in fact the opposite is
the case. They found that Mms2 and UEV1 acted in a
positive manner by binding to the E2 Ubc13 to form an
active complex. The Mms2 protein was originally identi-
fied in budding yeast as the target of mutations causing
MMS sensitivity; the mms2 mutants were subsequently
shown to be defective in post-replicative DNA repair.
Characterisation of the budding yeast ubc13 deletion
mutant showed it was also defective in post-replicative
DNA repair and that the ubc13 mutations was epistatic to
the mms2 mutant, consistent with the gene products
acting in the same pathway.
The phenotype of the mms2 and ubc13 yeast mutants raises
the question of what is the role of K63-linked
polyubiquitin chains in DNA repair? It appears that the
K63-linked chain is not being used as a signal for proteoly-
sis, as the K63R mutant has no apparent proteolytic defect,
and tagging proteins with these chains does not appear to
make them unstable. An alternative possibility is that spe-
cific proteins have to be tagged to mark the site of DNA
repair. These putative substrates would presumably play
an important role in the repair process. Do such K63-linked
polyubiquitin conjugates act as nucleating sites for a repair
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Figure 1
Polyubiquitin chains are now seen to be quite
versatile signals, acting in a number of quite
distinct cellular processes. (See text for details.)
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complex? One possibility, by analogy with K48-linked
polyubiquitin chains recognised by the Rpn10 proteasome
subunit, is that a specific receptor in the repair complex
recognises the K63-polyubiquitin chains and thereby
targets the repair complex to the site of DNA damage. 
Another unanswered question is how the Rad6 E2 fits into
this pathway. Like ubc13 mutants, rad6 mutants are
defective in post-replicative DNA repair; unlike the ubc13
mutants, however, their are many other facets to the rad6
mutant phenotype [9]. The Rad6 protein has been shown
to be required in the generation of the K48-linked
polyubiquitin chains that target substrates to the protea-
some by the so-called ‘N-end rule’ pathway, in which the
ubiquitination and degradation of a protein is determined
by the identity of its amino-terminal amino acid residue
[10]. Does the Rad6 protein function in DNA repair by
promoting the formation of K48-linked polyubiquitin
chains, or does it also promote formation of K63-linked
polyubiquitin chains, perhaps with the help of a cofactor
such as Mms2?
In the second study, Koegl et al. [8] identified a ubiquitin
chain elongation factor involved in generating K48-linked
polyubiquitin chains. Using an in vitro reconstitution
ubiquitination assay, the authors looked at the addition of
a polyubiquitin chain to a ‘ubiquitin fusion degradation’
(Ufd) model substrate by the purified E1 (Uba1), E2
(Ubc4) and E3 (Ufd3) enzymes that had previously been
implicated in this reaction. They found, surprisingly, that
only short chains of no more than three ubiquitin
monomers were generated by this in vitro system. As the
Rpn10 polyubiquitin-binding subunit of the 26S protea-
some prefers longer chains than those generated by this in
vitro system, it seemed that such short chains would not
be degraded by this multiprotein protease. Koegl et al. [8]
therefore searched for other ubiquitin-binding proteins
with a preference for such shorter chains.
By using short polyubiquitin chains as an affinity reagent,
Koegl et al. [8] purified a 110kDa protein with exactly
these properties. Mass spectrometry showed the protein to
be Ufd2, which had been identified previously in a genetic
screen for mutations that stabilised the Ufd substrate [11].
Why the ufd2 mutations caused such stabilisation had not
been clear. The key observation on the function of the
Ufd2 protein was that, when added to the in vitro ubiquiti-
nation assay, it caused a dramatic increase in the length of
the polyubiquitin chains synthesised. In a further series of
in vitro experiments, Koegl et al. [8] demonstrated that
Ufd2 was not needed for the initiation of ubiquitination,
and could not substitute for the E1, E2 or E3 activities.
Furthermore, Ufd2 did not appear to form the
thioester–ubiquitin intermediate found with the E1, E2
and E3 enzymes in this pathway, and did not seem to
interact physically with the E1, E2 or E3 proteins.
A simple model to account for these findings is that Ufd2
acts primarily by binding ubiquitin and in some way
influences the linkage between individual ubiquitin mol-
ecules. By analogy with the E1, E2 and E3 enzymes,
Koegl et al. [8] proposed the term E4 for proteins that,
like Ufd2, influence ubiquitin chain elongation. As 26S
proteasome activity is essential for cell growth and the
ufd2 deletion mutants are viable, it would appear that
Ufd2 activity is not involved in the formation of all
polyubiquitin chains. The ufd2 mutants are, however,
sensitive to a number of different stress conditions, such
as exposure to ethanol, heavy metals and amino acid ana-
logues. Such conditions are known to effect protein
folding, implicating the Ufd2 activity in the degradation
of misfolded proteins.
The identification of the E4 activity raises the possibility
that proteolysis can be regulated at the level of polyubiq-
uitin chain elongation. This may have important conse-
quences for cell regulation. One possibility is that it allows
the cell a second chance to reverse the consequences of
ubiquitination. For example, a potential substrate is first
ubiquitinated by the actions of the E1, E2 and E3
enzymes. This could have the effect of removing it from
the active pool into a ‘non-functional’ state, without com-
mitting the substrate to degradation by the 26S protea-
some. The cell would then have the choice of destroying
it by the action of the E4 enzyme or recycling it by the
action of ubiquitin hydrolases.
It now seems that the ubiquitin pathway is involved in
many different cell processes and could in fact be thought
of as a general signalling pathway in the cell (Figure 1).
Ubiquitination is involved in intracellular proteolysis by tar-
geting proteins for degradation by the 26S proteasome; it
has a well-proven role in the endocytosis of membrane
receptor proteins followed by targeting to the vacuole or
lysosome; and, via the K63-linked chains, it has now been
implicated in post-replicative DNA repair. Less clear is how
ubiquitin hydrolases, by removing ubiquitin from sub-
strates, function in regulating the above processes. What is
clear is that many more surprises are in store for those inves-
tigating the role ubiquitination plays in the life of a cell.
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